BNIP3 and pancreatic neoplasm: This has been shown in pancreatic adenocarcinoma where the promoter of BNIP3 turned out to be methylated in all BNIP3-negative pancreatic cancer cell lines and in eight out of 10 pancreatic adenocarcinoma samples [12].